milrinone has been researched along with 2019 Novel Coronavirus Disease in 4 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "A four- and a half-month-old girl with severe dilated cardiomyopathy due to neonatal enterovirus myocarditis, treated with diuretics and milrinone for the past 4 months, was infected with SARS-CoV-2." | 4.02 | SARS-CoV-2 infection in an infant with severe dilated cardiomyopathy. ( Knudsen, PK; Kristoffersen, AW; Møller, T, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kristoffersen, AW | 1 |
| Knudsen, PK | 1 |
| Møller, T | 1 |
| Magoon, R | 1 |
| Kohli, JK | 1 |
| Kashav, R | 1 |
| Blink, M | 1 |
| Buddingh', EP | 1 |
| Filippini, LHPM | 1 |
| Brinkman, DMC | 1 |
| Joosten, SA | 1 |
| Klein, RH | 1 |
| Vogel, DJ | 1 |
| Brame, A | 1 |
| Hanks, F | 1 |
| Remmington, C | 1 |
| Chung, N | 1 |
| Camporota, L | 1 |
4 other studies available for milrinone and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
SARS-CoV-2 infection in an infant with severe dilated cardiomyopathy.
Topics: Cardiomyopathy, Dilated; Cardiotonic Agents; COVID-19; Diarrhea; Diuretics; Echocardiography; Entero | 2021 |
Inhaled milrinone for sick COVID-19 cohort: A pathophysiology driven hypothesis!
Topics: Cardiopulmonary Bypass; COVID-19; Humans; Hypertension, Pulmonary; Milrinone; SARS-CoV-2 | 2021 |
[COVID-19-associated hyperinflammatory state in a 15-year-old female patient].
Topics: Adolescent; Anti-Inflammatory Agents; Aspirin; Cardiotonic Agents; COVID-19; COVID-19 Serological Te | 2020 |
Improved oxygenation with inhaled milrinone in mechanically ventilated patients with severe COVID-19.
Topics: Administration, Inhalation; Aged; COVID-19; Female; Humans; Hypertension, Pulmonary; Male; Middle Ag | 2021 |